VRTX · News · 20260823N

Acquisition / Partnership / Divestiture

VERTEX PHARMACEUTICALS INC / MA · 2026-08-23 · Importance 71 · Surprise 60

Vertex Pharmaceuticals is progressing with its planned acquisition of Crinetics Pharmaceuticals. The reported transaction value is approximately $10 billion, exceeding the materiality threshold. Crinetics was reported to have approximately $9 billion of market capitalization after its shares reached an all-time high of $84.80.

Key facts

• EP Wealth Advisors LLC acquired 9,027 shares of Vertex Pharmaceuticals Incorporated during the second quarter, valued at approximately $4,484,000. source